“…MOUD treatments are further complicated by co-occurring disorders (Wilson et al, 2018; Yin et al, 2015) along with polysubstance use, pain, anxiety, depression, and suicide attempts (Eyler, 2013; Jones & McCance-Katz, 2019; Yin et al, 2015; Zhong et al, 2019). Comorbid pain, chronic opioid use, and mental health issues can influence sleep (Axén, 2016; Krystal et al, 2017; Rosen et al, 2019), and indeed, problems with sleep along with nighttime respiratory disturbances have been reported in individuals receiving methadone-based MOUD (Peles et al, 2006; Stein et al, 2004). Such reports are expected based on the well-documented observation that acute opioid administration can reduce respiratory rate (Montandon et al, 2016) and chronic opioid use is associated with sleep-disordered breathing (Rosen et al, 2019).…”